Page last updated: 2024-08-23
ferric nitrilotriacetate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
ferric nitrilotriacetate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bonkovsky, HL; Hou, WH; Lambrecht, RW; Rossi, L; Shan, Y; Zheng, JY | 1 |
Other Studies
1 other study(ies) available for ferric nitrilotriacetate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
Topics: Basic-Leucine Zipper Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Deferoxamine; Fanconi Anemia Complementation Group Proteins; Ferric Compounds; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Humans; Iron; Liver Neoplasms; NF-E2-Related Factor 2; Nitrilotriacetic Acid; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Viral Proteins | 2009 |